Literature DB >> 28754609

The drug delivery field at the inflection point: Time to fight its way out of the egg.

Kinam Park1.   

Abstract

The world is becoming a better place, in part, by breakthrough findings by scientists. In the drug delivery field, many breakthrough formulations have been achieved helping patients deal with various diseases effectively. The recent progress, however, has been slowing down, and many important drug delivery problems have not been resolved. They can be overcome by understanding the causes and finding the remedies. For the last three decades, the field has been overwhelmed by nanotechnology, nanomedicine, and many nano-sized drug delivery systems. Disappointing outcomes of nano-sized formulations (nanoformulations) in clinical studies indicate that our overall approach of nanomedicine needs serious reevaluation. The limited advantages of nanoformulations were drastically exaggerated, and the assumptions used in nanomedicine and nanoformulations turned out to be inapplicable to clinical applications. The drug delivery field is at the strategic inflection point, and we all have to face the reality by absorbing the inconvenient truth and fight our way out of the egg to break the ill-conceived illusion of nanomedicine. Scientists are proud of their independent thinking and their work that can change the world, but the current climate does not allow them to be true scientists. The future of the drug delivery field depends on how effectively we can find talented young scientists with motivation, cultivate them with resources, provide them with an environment for the free exchange of ideas, and nurture them with purpose, passion, and the conviction of doing meaningful science.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Advantage of nanoformulations; Clinical trials; Future of drug delivery; Inconvenient truth; Inflection point; Limitations of nanoformulations; Nano-sized drug delivery systems; Nanoformulations

Mesh:

Year:  2017        PMID: 28754609     DOI: 10.1016/j.jconrel.2017.07.030

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  12 in total

Review 1.  Challenges and opportunities for drug delivery to the posterior of the eye.

Authors:  Fernando J Cabrera; Daniel C Wang; Kartik Reddy; Ghanashyam Acharya; Crystal S Shin
Journal:  Drug Discov Today       Date:  2019-06-05       Impact factor: 7.851

2.  The Use of Lactose as an Alternative Coating for Nanoparticles.

Authors:  Jamie L Betker; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2020-01-28       Impact factor: 3.534

3.  PD-L1- and calcitriol-dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease.

Authors:  Ryan Galea; Hendrik J Nel; Meghna Talekar; Xiao Liu; Joshua D Ooi; Megan Huynh; Sara Hadjigol; Kate J Robson; Yi Tian Ting; Suzanne Cole; Karyn Cochlin; Shannon Hitchcock; Bijun Zeng; Suman Yekollu; Martine Boks; Natalie Goh; Helen Roberts; Jamie Rossjohn; Hugh H Reid; Ben J Boyd; Ravi Malaviya; David J Shealy; Daniel G Baker; Loui Madakamutil; A Richard Kitching; Brendan J O'Sullivan; Ranjeny Thomas
Journal:  JCI Insight       Date:  2019-09-19

Review 4.  Tumor heterogeneity and nanoparticle-mediated tumor targeting: the importance of delivery system personalization.

Authors:  K Laxmi Swetha; Aniruddha Roy
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

Review 5.  Quantum dots in biomedical applications.

Authors:  Angela M Wagner; Jennifer M Knipe; Gorka Orive; Nicholas A Peppas
Journal:  Acta Biomater       Date:  2019-05-11       Impact factor: 8.947

6.  Escaping to silence using an endosome-disrupting polymer.

Authors:  Jamie L Betker; Scott G Tilden; Thomas J Anchordoquy
Journal:  Mol Ther       Date:  2021-09-23       Impact factor: 12.910

Review 7.  Craft of Co-encapsulation in Nanomedicine: A Struggle To Achieve Synergy through Reciprocity.

Authors:  Sourav Bhattacharjee
Journal:  ACS Pharmacol Transl Sci       Date:  2022-05-02

8.  Evolution of drug delivery systems: From 1950 to 2020 and beyond.

Authors:  Haesun Park; Andrew Otte; Kinam Park
Journal:  J Control Release       Date:  2021-12-29       Impact factor: 11.467

Review 9.  Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization.

Authors:  Susan Hua; Maria B C de Matos; Josbert M Metselaar; Gert Storm
Journal:  Front Pharmacol       Date:  2018-07-17       Impact factor: 5.810

10.  The availability of drug by liposomal drug delivery : Individual kinetics and tissue distribution of encapsulated and released drug in mice after administration of PEGylated liposomal prednisolone phosphate.

Authors:  Evelien A W Smits; José A Soetekouw; Ebel H E Pieters; Coen J P Smits; Nicolette de Wijs-Rot; Herman Vromans
Journal:  Invest New Drugs       Date:  2018-12-13       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.